SyntekaBio secures 6.48B KRW colocation contract
신테카바이오
226330
Signal Score
Historical Avg Return (5d)
+0.12%
Data Coverage
100%n=750
Risk-adjusted indicator based on 750 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Amount: 6.48 Billion KRW
- • % of Recent Revenue: 188.96%
- • Contract Period: November 1, 2026 - October 31, 2029 (36 months)
- • Recent Revenue (2025 consolidated): 3.43 Billion KRW
AI Analysis Summary
SyntekaBio, Inc. announced a colocation service contract worth 6.48 billion KRW with Atto Research. This contract represents a significant 188.96% of the company's recent consolidated revenue of 3.43 billion KRW (2025). The 36-month contract runs from November 1, 2026, to October 31, 2029, with monthly cash payments. This substantial contract is expected to have a strong positive impact on future revenue and profitability, indicating significant business growth.
How This Event Is Evaluated
Strategic Contract Evaluation
Contract events are evaluated by measuring business scale, revenue relevance, counterparty quality, and execution visibility.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Contract size relative to company revenue
- Expected revenue impact
- Counterparty quality
- Contract duration and execution period
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.